首页> 外文期刊>Hematological oncology >Radiation therapy for localized low-grade non-Hodgkin's lymphomas.
【24h】

Radiation therapy for localized low-grade non-Hodgkin's lymphomas.

机译:局部低度非霍奇金淋巴瘤的放射治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

The most common low grade B-cell non-Hodgkin's lymphomas are follicular lymphomas, and extranodal marginal zone lymphomas, also known as mucosa-associated lymphoid tissue (MALT) lymphomas. Localized presentations of follicular lymphoma occur in 20-30% of cases, while for MALT lymphomas, stage I-II disease presentations occur in 70-90%. These are radiation-sensitive lymphomas. Following moderate dose local radiation treatment (30-35 Gy) for these stage I and II low grade lymphomas, the clinical results indicate long-term local control and possible cure. While local control is achieved with minimal morbidity with involved-field radiation therapy, a significant proportion of patients relapse with systemic disease outside of radiation fields. For follicular lymphoma, this occurs in approximately 50% of patients after 15 years, and for non-gastric MALT lymphoma, 30-40% after 10 years. Although patients with relapsed systemic disease are not curable with chemotherapy, the disease often behaves in an indolentfashion and prolonged survival is observed. For gastric MALT lymphomas, radiation therapy is indicated in patients whose lymphoma did not respond to Helicobacter pylori eradication therapy, or in gastric lymphoma not related to this microorganism. The subject of causative agents responsible for non-gastric MALT lymphomas is under active study and the identification of putative microorganisms will lead to improved treatment strategies for these unusual lymphomas, similar to the success in gastric lymphomas over the last decade. Copyright (c) 2005 John Wiley & Sons, Ltd.
机译:最常见的低级B细胞非霍奇金淋巴瘤是滤泡性淋巴瘤和结外边缘区淋巴瘤,也称为粘膜相关淋巴样组织(MALT)淋巴瘤。滤泡性淋巴瘤的局部表现在20-30%的病例中发生,而MALT淋巴瘤的I-II期疾病表现在70-90%的病例中发生。这些是放射敏感性淋巴瘤。对于这些I期和II期低级淋巴瘤进行中等剂量的局部放射治疗(30-35 Gy)后,临床结果表明可以长期进行局部控制并可能治愈。虽然通过介入电场放射治疗可以使发病率降至最低,但可以实现局部控制,但相当一部分患者因放射线以外的全身疾病复发。对于滤泡性淋巴瘤,这在15年后的患者中约占50%,而对于非胃MALT淋巴瘤,在10年后的患者中占30-40%。尽管复发的全身性疾病患者无法通过化学疗法治愈,但该疾病常表现为惰性,并且可以延长生存期。对于胃MALT淋巴瘤,在淋巴瘤对幽门螺杆菌根除治疗无反应的患者或与该微生物无关的胃淋巴瘤中,建议进行放射治疗。负责非胃MALT淋巴瘤的病原体正在积极研究中,对假定微生物的鉴定将导致这些异常淋巴瘤的治疗策略得到改善,类似于最近十年在胃淋巴瘤方面的成功。版权所有(c)2005 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号